Diagnosis and Treatment of Opioid Use Disorder in 2020
Author:
- 26 May 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (20) , 2082-2083
Abstract
This JAMA Insights Clinical Update reviews current approaches to screening for and managing opioid use disorder, summarizing available screening instruments, diKeywords
This publication has 9 references indexed in Scilit:
- Trends in Intentional and Unintentional Opioid Overdose Deaths in the United States, 2000-2017JAMA, 2019
- Medication-Based Treatment to Address Opioid Use DisorderJAMA, 2019
- Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use DisorderJAMA Psychiatry, 2019
- Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet, 2019
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialThe Lancet, 2018
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesBMJ, 2017
- Validation of Self-Administered Single-Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug Use in Primary Care PatientsJournal of General Internal Medicine, 2015
- Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcoholDrug and Alcohol Dependence, 2013
- Diagnostic and Statistical Manual of Mental Disorders2013